BACKGROUND: Brain arteriovenous malformations (BAVMs) are a tangle of abnormal vessels directly shunting blood from the arterial to venous circulation and an important cause of intracranial hemorrhage (ICH). EphB4 is involved in arterial-venous determination during embryogenesis; altered signaling could lead to vascular instability resulting in ICH. We investigated the association of single-nucleotide polymorphisms (SNPs) and haplotypes in EPHB4 with risk of ICH at clinical presentation in patients with BAVM. METHODS AND RESULTS: Eight haplotype-tagging SNPs spanning approximately 29 kb were tested for association with ICH presentation in 146 white patients with BAVM (phase I: 56 ICH, 90 non-ICH) using allelic, haplotypic, and principal components analysis. Associated SNPs were then genotyped in 102 additional cases (phase II: 37 ICH, 65 non-ICH), and data were combined for multivariable logistic regression. Minor alleles of 2 SNPs were associated with reduced risk of ICH presentation (rs314313_C, P=0.005; rs314308_T, P=0.0004). Overall, haplotypes were also significantly associated with ICH presentation (chi(2)=17.24, 6 df, P=0.008); 2 haplotypes containing the rs314308 T allele (GCCTGGGT, P=0.003; GTCTGGGC, P=0.036) were associated with reduced risk. In principal components analysis, 2 components explained 91% of the variance and complemented haplotype results by implicating 4 SNPs at the 5' end, including rs314308 and rs314313. These 2 SNPs were replicated in the phase II cohort, and combined data resulted in greater significance (rs314313, P=0.0007; rs314308, P=0.00008). SNP association with ICH presentation persisted after adjusting for age, sex, BAVM size, and deep venous drainage. CONCLUSIONS: EPHB4 polymorphisms are associated with risk of ICH presentation in patients with BAVM, warranting further study.
BACKGROUND:Brain arteriovenous malformations (BAVMs) are a tangle of abnormal vessels directly shunting blood from the arterial to venous circulation and an important cause of intracranial hemorrhage (ICH). EphB4 is involved in arterial-venous determination during embryogenesis; altered signaling could lead to vascular instability resulting in ICH. We investigated the association of single-nucleotide polymorphisms (SNPs) and haplotypes in EPHB4 with risk of ICH at clinical presentation in patients with BAVM. METHODS AND RESULTS: Eight haplotype-tagging SNPs spanning approximately 29 kb were tested for association with ICH presentation in 146 white patients with BAVM (phase I: 56 ICH, 90 non-ICH) using allelic, haplotypic, and principal components analysis. Associated SNPs were then genotyped in 102 additional cases (phase II: 37 ICH, 65 non-ICH), and data were combined for multivariable logistic regression. Minor alleles of 2 SNPs were associated with reduced risk of ICH presentation (rs314313_C, P=0.005; rs314308_T, P=0.0004). Overall, haplotypes were also significantly associated with ICH presentation (chi(2)=17.24, 6 df, P=0.008); 2 haplotypes containing the rs314308 T allele (GCCTGGGT, P=0.003; GTCTGGGC, P=0.036) were associated with reduced risk. In principal components analysis, 2 components explained 91% of the variance and complemented haplotype results by implicating 4 SNPs at the 5' end, including rs314308 and rs314313. These 2 SNPs were replicated in the phase II cohort, and combined data resulted in greater significance (rs314313, P=0.0007; rs314308, P=0.00008). SNP association with ICH presentation persisted after adjusting for age, sex, BAVM size, and deep venous drainage. CONCLUSIONS:EPHB4 polymorphisms are associated with risk of ICH presentation in patients with BAVM, warranting further study.
Authors: Ludmila Pawlikowska; Mary N Tran; Achal S Achrol; Charles E McCulloch; Connie Ha; Denise L Lind; Tomoki Hashimoto; Jonathan Zaroff; Michael T Lawton; Douglas A Marchuk; Pui-Yan Kwok; William L Young Journal: Stroke Date: 2004-08-26 Impact factor: 7.914
Authors: Helen Kim; Pirro G Hysi; Ludmila Pawlikowska; Annie Poon; Esteban González Burchard; Jonathan G Zaroff; Stephen Sidney; Nerissa U Ko; Achal S Achrol; Michael T Lawton; Charles E McCulloch; Pui-Yan Kwok; William L Young Journal: Cerebrovasc Dis Date: 2008-12-18 Impact factor: 2.762
Authors: Nicole K Noren; Mark Lu; Andrew L Freeman; Mitchell Koolpe; Elena B Pasquale Journal: Proc Natl Acad Sci U S A Date: 2004-04-05 Impact factor: 11.205
Authors: Tomoki Hashimoto; Michael T Lawton; Gen Wen; Guo-Yuan Yang; Thomas Chaly; Campbell L Stewart; Holly K Dressman; Nicholas M Barbaro; Douglas A Marchuk; William L Young Journal: Neurosurgery Date: 2004-02 Impact factor: 4.654
Authors: Bahar Mikhak; Shantel Weinsheimer; Ludmila Pawlikowska; Annie Poon; Pui-Yan Kwok; Michael T Lawton; Yongmei Chen; Jonathan G Zaroff; Stephen Sidney; Charles E McCulloch; William L Young; Helen Kim Journal: Cerebrovasc Dis Date: 2011-01-07 Impact factor: 2.762
Authors: Peter B Sporns; Heather J Fullerton; Sarah Lee; Helen Kim; Warren D Lo; Mark T Mackay; Moritz Wildgruber Journal: Nat Rev Dis Primers Date: 2022-02-24 Impact factor: 52.329
Authors: Shantel Weinsheimer; Ari D Brettman; Ludmila Pawlikowska; D Christine Wu; Michael R Mancuso; Frank Kuhnert; Michael T Lawton; Stephen Sidney; Jonathan G Zaroff; Charles E McCulloch; William L Young; Calvin Kuo; Helen Kim Journal: Transl Stroke Res Date: 2012-08-14 Impact factor: 6.829
Authors: Amy L Akers; Karen L Ball; Marianne Clancy; Anne M Comi; Marie E Faughnan; Rashmi Gopal-Srivastava; Thomas P Jacobs; Helen Kim; Jeffrey Krischer; Douglas A Marchuk; Charles E McCulloch; Leslie Morrison; Marsha Moses; Claudia S Moy; Ludmilla Pawlikowska; William L Young Journal: J Rare Disord Date: 2013-04-01